Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by jfm1330on May 18, 2022 7:24pm
70 Views
Post# 34694075

RE:RE:RE:RE:RE:RE:RE:We have enough difficulty solving TH's issues

RE:RE:RE:RE:RE:RE:RE:We have enough difficulty solving TH's issuesYou knew you were investing in a Montreal based company when you decided to invest in it. Sell your shares and avoid companies from Quebec. And you lie again, there is nochanges coming in Quebec that will force company not use english. This is pure invention on your part. Also, it sure that board meetings are in english, and also management meeting with John Leasure and Connor Walsh. Be sure they were not force to learn french to work for Thera. All this subject is pure cr*p.

jeffm34 wrote: All I care about is what's best for my investment in Thera. No one here can argue the company is better off where they are now than if they moved somewhere like Boston/Cambridge. There they have access to a more diverse workforce and investment community and would gain more exposure. The changes coming to Quebec will make that difference even greater and the case for moving even stronger 


<< Previous
Bullboard Posts
Next >>